High-dose busulfan, melphalan and thiotepa as consolidation for non-inflammatory high-risk breast cancer.
Gutierrez-Delgado F, Holmberg LA, Hooper H, Appelbaum FR, Livingston RB, Maziarz RT, Weiden P, Rivkin S, Montgomery P, Kawahara K, Bensinger W.
Gutierrez-Delgado F, et al. Among authors: livingston rb.
Bone Marrow Transplant. 2000 Jul;26(1):51-9. doi: 10.1038/sj.bmt.1702461.
Bone Marrow Transplant. 2000.
PMID: 10918405
Clinical Trial.